3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
2
Other neoplasm
1
Conditions
Precancerous Conditions
12
Neoplasms
4
Myelodysplastic Syndromes
4
Leukemia, Myeloid, Acute
4
Leukemia
4
Preleukemia
3
Neoplasms by Histologic Type
3
Keratosis, Actinic
3
Hematologic Diseases
3
Bone Marrow Diseases
3
Thrombocythemia, Essential
2
Skin Diseases
2
Primary Myelofibrosis
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Obesity-Related Malignant Neoplasm
2
Myeloproliferative Disorders
2
Myelodysplastic-Myeloproliferative Diseases
2
Multiple Myeloma
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia, Biphenotypic, Acute
2
Immunoproliferative Disorders
2
Immune System Diseases
2
Hodgkin Disease
2
Graft vs Host Disease
2
Endometrial Neoplasms
2
Waldenstrom Macroglobulinemia
1
Venentoclax
1
Uterine Prolapse
1
Interventions
Robotic Surgical Procedures
1
Hysterectomy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Uterine Prolapse
×
Other neoplasm
×
90 days
×
Clear all
NCT07120945
2026-06-02
Embrace Gyn
Medtronic - MITG
Phase NA
Active not recruiting
70 enrolled